Cost remains a major factor for employers as the popular drug for weight loss represented 11.4% of annual claims for corporations in 2025.

Cost remains a major factor for employers as the popular drug for weight loss represented 11.4% of annual claims for corporations in 2025.

Despite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients taking are still taking cheaper weight-loss alternatives.